Patents-Review.com
🔗 Permalink
Assignee profile:

ALFASIGMA S.P.A.

City:

Bologna

Country:

Italy

Published Applications:

28

Last publication date:

2026-05-07

Patent Grants:

20

Last grant date:

2026-02-24

Top Inventors for applications by ALFASIGMA S.P.A.

These are the the leading inventors for applications assigned to ALFASIGMA S.P.A.:

Recent patent applications by ALFASIGMA S.P.A.

ALFASIGMA S.P.A. based in Bologna, IT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-05-07
US20260124194A1
Human necessities

VELUSETRAG FOR USE IN THE TREATMENT OF CHRONIC INTESTINAL PSEUDO-OBSTRUCTION (CIPO)

 #2 | 2025-11-27
US20250360177A1
Human necessities

FERMENTATION PRODUCT FOR THE TREATMENT OF INFLAMMATORY DISEASES

 #3 | 2025-10-23
US20250325606A1
Human necessities

LACTICASEIBACILLUS PARACASEI DG(R) CNCM I-1572 DSM 34154 FOR USE IN A METHOD OF TREATING DYSBIOSIS IN PATIENTS WITH IBS

 #4 | 2024-10-24
US20240350567A1
Human necessities

USE OF LACTOBACILLUS PARACASEI BACTERIAL STRAINS IN THE TREATMENT OF NEWBORNS

 #5 | 2024-10-03 ✅ Patent 12,558,360 granted on 2026-02-24
US20240325405A1
Human necessities

COMPOUND USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

 #6 | 2024-08-22 ✅ Patent 12,502,394 granted on 2025-12-23
US20240277725A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING A JAK INHIBITOR

 #7 | 2023-12-21 ✅ Patent 12,234,235 granted on 2025-02-25
US20230406857A1
Chemistry; metallurgy

Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders

 #8 | 2023-06-22 ✅ Patent 12,472,214 granted on 2025-11-18
US20230190833A1
Human necessities

BACTERIAL STRAINS, THE COMPOSITIONS THEREOF AND USE THEREOF IN A METHOD FOR THE TREATMENT OF VITAMIN D DEFICIENCY, AND DISORDERS ASSOCIATED THEREWITH

 #9 | 2023-06-15
US20230181475A1
Human necessities

COMPOSITION COMPRISING METHYLFOLATE

 #10 | 2023-04-06 ✅ Patent 12,201,729 granted on 2025-01-21
US20230104254A1
Human necessities

Process for mesalazine solid formulations

 #11 | 2022-10-27 ✅ Patent 12,447,183 granted on 2025-10-21
US20220339216A1
Human necessities

BACTERIAL STRAINS, THEIR COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

 #12 | 2022-08-04
US20220241193A1
Human necessities

PHARMACEUTICAL COMPOSITIONS IN THE FORM OF GEL CONTAINING XYLOGLUCAN AND ALCOHOLS FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS

 #13 | 2021-12-02 ✅ Patent 12,042,498 granted on 2024-07-23
US20210369727A1
Human necessities

Compound useful for the treatment of degenerative and inflammatory diseases

 #14 | 2021-09-30 ✅ Patent 12,329,758 granted on 2025-06-17
US20210299135A1
Human necessities

METHODS FOR THE TREATMENT OF PSORIATIC ARTHRITIS

 #15 | 2021-08-12
US20210244714A1
Human necessities

PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE

 #16 | 2021-08-05 ✅ Patent 11,896,631 granted on 2024-02-13
US20210236565A1
Human necessities

Probiotics for use in the treatment of diverticulosis and diverticular disease

 #17 | 2021-06-24 ✅ Patent 11,751,597 granted on 2023-09-12
US20210186075A1
Human necessities

Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems

 #18 | 2021-05-06
US20210128740A1
Human necessities

HDAC INHIBITORS-BASED ANTIBODY DRUG CONJUGATES (ADCs) AND USE IN THERAPY

 #19 | 2020-10-15 ✅ Patent 11,433,043 granted on 2022-09-06
US20200323809A1
Human necessities

Compounds useful for increasing neurogenesis in neural tissue

 #20 | 2020-01-30 ✅ Patent 10,793,925 granted on 2020-10-06
US20200032357A1
Chemistry; metallurgy

for the production of conjugated linoleic acid, nutritional and pharmaceutical preparations containing it and uses thereof

 #21 | 2020-01-02 ✅ Patent 10,703,763 granted on 2020-07-07
US20200002350A1
Chemistry; metallurgy

Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

 #22 | 2019-10-17 ✅ Patent 11,241,452 granted on 2022-02-08
US20190314402A1
Human necessities

Oral compositions for the treatment of gastroesophageal reflux

 #23 | 2019-09-26 ✅ Patent 11,752,179 granted on 2023-09-12
US20190290706A1
Human necessities

Medical use of probiotics

 #24 | 2019-01-31 ✅ Patent 11,642,339 granted on 2023-05-09
US20190030022A1
Human necessities

Methods of treating symptoms of gastroparesis using velusetrag

 #25 | 2018-12-13 ✅ Patent 10,428,086 granted on 2019-10-01
US20180354971A1
Chemistry; metallurgy

Solvated crystal form of rifaximin, production, compositions and uses thereof

 #26 | 2017-09-14 ✅ Patent 10,258,657 granted on 2019-04-16
US20170258860A1
Human necessities

Therapeutic and nutritional compositions for functional gastrointestinal disorders

 #27 | 2017-05-04 ✅ Patent 10,300,035 granted on 2019-05-28
US20170119720A1
Human necessities

Homogeneous formulation comprising omega-3 polyunsatured fatty acid and resveratrol for oral administration

 #28 | 2016-10-13 ✅ Patent 11,839,634 granted on 2023-12-12
US20160296569A1
Human necessities

Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid

Also check out ALFASIGMA S.P.A.'s (Bologna, Italy) applicant profile with 23 patent applications submitted.

AssigneeID:

144598 ⎘